Cargando…
Intravenous administration of mesenchymal stem cells prevents angiotensin II-induced aortic aneurysm formation in apolipoprotein E-deficient mouse
BACKGROUND: Mesenchymal stem cells (MSCs) are known to be capable of suppressing inflammatory responses. We previously reported that intra-abdominal implantation of bone marrow-derived MSCs (BM-MSCs) sheet by laparotomy attenuated angiotensin II (AngII)-induced aortic aneurysm (AA) growth in apolipo...
Autores principales: | Fu, Xian-ming, Yamawaki-Ogata, Aika, Oshima, Hideki, Ueda, Yuichi, Usui, Akihiko, Narita, Yuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726376/ https://www.ncbi.nlm.nih.gov/pubmed/23875706 http://dx.doi.org/10.1186/1479-5876-11-175 |
Ejemplares similares
-
Administration of anti-inflammatory M2 macrophages suppresses progression of angiotensin II-induced aortic aneurysm in mice
por: Ashida, Shinichi, et al.
Publicado: (2023) -
Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Induces M2 Macrophage Polarization and Inhibits Murine Aortic Aneurysm Formation
por: Kawai, Yohei, et al.
Publicado: (2019) -
A review of current status of cell-based therapies for aortic aneurysms
por: Yamawaki-Ogata, Aika, et al.
Publicado: (2023) -
The efficacy of immediate bridging thoracic endovascular aortic repair for ruptured infected thoracic aortic aneurysms
por: Ito, Hideki, et al.
Publicado: (2019) -
Development of novel waxy bone haemostatic agents composed of biodegradable polymers with osteogenic-enhancing peptides in rabbit models
por: Ohno, Tsukasa, et al.
Publicado: (2023)